2 
The following non-voting members and liaison representatives were present : 
Dr. Darryl Banks, Environmental Protection Agency; Dr. Charlotte Bell, U. S. 
Department of Justice; Dr. Howard Bermann (ALT.), U. S. Veterans Administration; 
Dr. Donald DeVincenzi, National Aeronautics and Space Administration; Dr. George 
IXida, U. S. Department of Energy; Dr. Timothy J. Henry, Food and Drug Adminis- 
tration; Dr. Herman Lewis, National Science Foundation; Dr. David Logan, U. S. 
Department of Labor; Dr. Sue Iblin, U. S. Department of Agriculture; and 
Dr. William J. Walsh, III, U. S. Department of State. 
Other National Institutes of Health staff present were : 
Dr. Marilyn Bach, NIAID; Efcr. Stanley Bar ban, NIAID; Dr. W. Brine tt Barkley, ORS; 
Mrs. Betty Butler, NIAID; Dr. John Irwin, ORS; Dr. Richard Krause, NIAID; 
Ms. Chris Krutzsch, NIAID; Dr. Robert McKinney, ORS; Dr. Elizabeth Milewski, 
NIAID; Dr. Stanley Nagle, NIAID; Dr. John Nutter, NIAID; Dr. Maxine Singer, NCI; 
Dr. Bernard Talbot, OD; Dr. Rudolf Wanner, ORS; and Dr. Burke Zimmerman, OD. 
Others in attendance for all or part of the meeting were : 
Dr. Lucile Adanson, Occupational Safety and Health Administration; Dr. E. A. 
Agostini, Pfizer, Inc.; Dr. D. E. Baldwin, Schering Oorp.; Ms. Irene Brandt, 
Eli Lilly & Co.; Et. Peter Bostock, New Brunswick Scientific Co., Inc.; 
Ms. Vicky Cahan, McGraw Hill; Dr. C. T. Chen, Occupational Safety and Health 
Administration; Mr. Jeffrey Christy, Blue Sheet; Mr. Chris Coley, Harvard 
Medical School student; Dr. Aileen Compton, Smith-Kline & French; Mr. David 
Dickson, Nature; Dr. Diana Dutton, Stanford University; Dc, John Grupenhoff, 
Washington Counsel/Medicine and Health; Dr. Lowell Harmison, Office of Assistant 
Secretary for Health; Dr. Zsolt Harsanyi, Office of Technology Assesment; 
Ms. Flo Hassell, Office of Assistant Secretary for Health; Mr. Phil Hilts, 
Washington Post; Dr. Paul Hung, Abbott Research Laboratories; Dr. James Hunt, 
Chemapec; Dr. Evelyn Hurlburt, Johns Hopkins School of Hygiene; Mr. Philip 
Janus, Office of Assistant Secretary for Health; Dc. Dorothy Jessup, U. S. 
Department of Agriculture; Dr. Irving Johnson, Eli Lilly & Co.; Dr. Attila I. 
Kadar, Fbod and Drug Administration; Mr. B. Khosrovi, Cetus Corp. ; Mr. Edward 
Kbrwek, Kells & Heckman; Ms. Ann Lallande, McGraw Hill; Dr. Paul Leibowitz, 
Schering Corp.; Ms. Carter Leonard, Blue Sheet; Dr. M. A. Levin, Environmental 
Protection Agency; Dr. James McCullough, Library of Congress; Dr. Henry I. 
Miller, Food and Drug Administration; Mr. Claude Nash, Smith-Kline & French; 
Dr. DeLill Nasser, National Science Foundation; Dr Ann Norberg, Monsanto Co . ; 
Dr. Arthur Norberg, National Science Foundation; Mr. Seth Pauker, National 
Institute for Occupational Safety and Health; Dr. William Pilacinski, Molecular 
Genetics, Inc.; Mr. Alvin Pol an, SELF; Dr. John Richardson, Centers for 'Disease 
Control; Mr. Harold Schmeck, New York Times; Dr. Brian Sheehan, Consultant, Amos 
Corp.; Mr. Vincent Sinrons, Genex Corp.; Dr. Mark Smith, CNAM, Paris; Mr. Jeff 
9warz, Teknekron, Inc.; Mr. Dean Taylor, Smith-Kline & French; Dr. Charles 
Weiner, Massachusetts Institute of Technology; Dr. Marvin Weinstein, Schering 
Corp.; Dr. Susan Wright, University of Michigan; Dr. Bill Young, Genentech, 
Inc.; and Dr. Robert Zaugg, Teknekron, Inc. 
[ 161 ] 
